Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease have?
Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease has 26 citations in the OpenAlex counts ScholarIQ stores.
When was Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease published?
Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease has 2020 year in the ScholarIQ index.
What is the open-access status of Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease?
Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease has gold oa status in the ScholarIQ index.
What is the DOI of Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease?
The DOI for Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease is on the source record.
What is the PMID of Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease?
The PMID for Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease is on the source record.
What is the OpenAlex record for Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease?
The OpenAlex for Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease is on the source record.